Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with one marrow MSCs in vitro

World Journal of Gastroenterology

Volumn 17, Issue 19, 2011, Pages 2397-2406

  Shi, Xiao Lei ^a,b,c   Gu, Jin Yang ^a,b,c   Zhang, Yue ^a,c,d   Han, Bing ^a,c   Xiao, Jiang Qiang ^a,c   Yuan, Xian Wen ^a,c   Zhang, Ning ^a,e   Ding, Yi Tao ^a,b,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Jiangsu Province's Key Medical Center for Hepatobiliary Disease   (China)

^c NANJING UNIVERSITY   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^e Nanjing Second Hospital   (China)

Author keywords

Acute on chronic liver failure serum; Bone marrow marrow mesenchymal stem cells; Co culture; Hepatocyte based modality; Primary hepatocytes

Indexed keywords

EPIDERMAL GROWTH FACTOR; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE ON CHRONIC LIVER FAILURE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL FUNCTION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; LIVER CELL; LIVER FAILURE; MALE; MESENCHYMAL STEM CELL; MONOLAYER CULTURE; NONHUMAN; SERUM;

EID: 79957858539     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i19.2397     Document Type: Article

References (42)

1. Riordan SM, Williams R. Perspectives on liver failure: past and future. Semin Liver Dis 2008; 28: 137-141
2. Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis 2008; 28: 201-209
3. Sgroi A, Serre-Beinier V, Morel P, Bühler L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 2009; 87: 457-466
4. Kobayashi N. Life support of artificial liver: development of a bioartificial liver to treat liver failure. J Hepatobiliary Pancreat Surg 2009; 16: 113-117
5. Pietrosi G, Vizzini GB, Gruttadauria S, Gridelli B. Clinical applications of hepatocyte transplantation. World J Gastroenterol 2009; 15: 2074-2077
6. Poyck PP, van Wijk AC, van der Hoeven TV, de Waart DR, Chamuleau RA, van Gulik TM, Oude Elferink RP, Hoekstra R. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol 2008; 48: 266-275
7. Glanemann M, Gaebelein G, Nussler N, Hao L, Kronbach Z, Shi B, Neuhaus P, Nussler AK. Transplantation of monocytederived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure. Ann Surg 2009; 249: 149-154
8. Donato MT, Lahoz A, Montero S, Bonora A, Pareja E, Mir J, Castell JV, Gómez-Lechón MJ. Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant 2008; 17: 1211-1219
9. Newsome PN, Tsiaoussis J, Masson S, Buttery R, Livingston C, Ansell I, Ross JA, Sethi T, Hayes PC, Plevris JN. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 2004; 40: 636-645
10. Saich R, Selden C, Rees M, Hodgson H. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy. Artif Organs 2007; 31: 732-742
11. Abrahamse SL, van de Kerkhove MP, Sosef MN, Hartman R, Chamuleau RA, van Gulik TM. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs 2002; 25: 966-974
12. Ito Y, Eguchi S, Kamohara Y, Inuo H, Yamanouchi K, Okudaira S, Yanaga K, Furui J, Kanematsu T. Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system. Int J Artif Organs 2004; 27: 303-310
13. Mitry RR, Bansal S, Hughes RD, Mieli-Vergani G, Dhawan A. In vitro effects of sera from children with acute liver failure on metabolic and synthetic activity of cryopreserved human hepatocytes. J Pediatr Gastroenterol Nutr 2009; 48: 604-607
14. Yamashita Y, Shimada M, Tsujita E, Shirabe K, Ijima H, Nakazawa K, Sakiyama R, Fukuda J, Funatsu K, Sugimachi K. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure. Cell Transplant 2002; 11: 379-384
15. Nagaki M, Naito T, Ohnishi H, Akaike T, Muto Y, Moriwaki H. Effects of plasma from patients with fulminant hepatic failure on function of primary rat hepatocytes in threedimensional culture. Liver Int 2005; 25: 1010-1017
16. Gu J, Shi X, Zhang Y, Chu X, Hang H, Ding Y. Establishment of a three-dimensional co-culture system by porcine hepatocytes and bone marrow mesenchymal stem cells in vitro. Hepatol Res 2009; 39: 398-407
17. Gu J, Shi X, Zhang Y, Ding Y. Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro. J Cell Physiol 2009; 219: 100-108
18. Gu J, Shi X, Chu X, Zhang Y, Ding Y. Contribution of bone marrow mesenchymal stem cells to porcine hepatocyte culture in vitro. Biochem Cell Biol 2009; 87: 595-604
19. Yuan Y, Iloeje U, Li H, Hay J, Yao GB. Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program. Value Health 2008; 11 Suppl 1: S11-S22
20. Cai CJ, Chen HA, Lu MQ, Chen GH. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B. Chin Med J (Engl) 2008; 121: 2065-2069
21. Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Nephrol Dial Transplant 2007; 22 Suppl 8: viii37-viii46
22. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217-222
23. Liu J, Kjaergard LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol. Liver 2002; 22: 433-438
24. Poyck PP, Mareels G, Hoekstra R, van Wijk AC, van der Hoeven TV, van Gulik TM, Verdonck PR, Chamuleau RA. Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liver. Artif Organs 2008; 32: 116-126
25. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Müller AR, Steinmüller T, Denner J, Neuhaus P, Gerlach JC. Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation 2003; 10: 460-469
26. Barreiros AP, Sprinzl M, Rosset S, Höhler T, Otto G, Theobald M, Galle PR, Strand D, Strand S. EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytes. Int J Cancer 2009; 124: 120-129
27. Ogata A, Kitano M, Yamanaka J, Yamasaki T, Hashimoto N, Iwasaki T, Hamano T, Fujimoto J, Kakishita E. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003; 30: 1093-1096
28. Zeisberg M, Kramer K, Sindhi N, Sarkar P, Upton M, Kalluri R. De-differentiation of primary human hepatocytes depends on the compositio n of specialized liver basement membrane. Mol Cell Biochem 2006; 283: 181-189
29. Price JA, Caldwell J, Hewitt NJ. The effect of EGF and the comitogen, norepinephrine, on the proliferative responses of fresh and cryopreserved rat and mouse hepatocytes. Cryobiology 2006; 53: 182-193
30. Zinchenko YS, Coger RN. Engineering micropatterned surfaces for the coculture of hepatocytes and Kupffer cells. J Biomed Mater Res A 2005; 75: 242-248
31. Bhatia SN, Balis UJ, Yarmush ML, Toner M. Effect of cellcell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999; 13: 1883-1900
32. Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, Biglarnia A, Kamler M, Niehues EM, Frilling A, Broelsch CE, Schlaak JF. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007; 138: 291-299
33. Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, Nakagawa K, Yoshidome H, Kataoka M, Nakajima N. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001; 34: 683-689
34. Assy N, Spira G, Paizi M, Shenkar L, Kraizer Y, Cohen T, Neufeld G, Dabbah B, Enat R, Baruch Y. Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol 1999; 30: 911-915
35. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996; 226: 176-179
36. Akiyoshi F, Sata M, Suzuki H, Uchimura Y, Mitsuyama K, Matsuo K, Tanikawa K. Serum vascular endothelial growth factor levels in various liver diseases. Dig Dis Sci 1998; 43: 41-45
37. Namisaki T, Yoshiji H, Kojima H, Yoshii J, Ikenaka Y, Noguchi R, Sakurai S, Yanase K, Kitade M, Yamazaki M, Asada K, Uemura M, Nakamura M, Fukui H. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. J Hepatol 2006; 44: 568-575
38. Auth MK. Are hepatic growth factors predictors of clinical outcome in fulminant hepatic failure? J Pediatr Gastroenterol Nutr 2007; 44: 168-170
39. Kagiwada H, Yashiki T, Ohshima A, Tadokoro M, Nagaya N, Ohgushi H. Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med 2008; 2: 184-189
40. Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005; 32: 270-279
41. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-1170
42. Patel SA, Sherman L, Munoz J, Rameshwar P. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) 2008; 56: 1-8